Literature DB >> 3584854

Effects of rifampicin on the peripheral turnover kinetics of thyroid hormones in mice and in men.

C Finke, C Juge, M Goumaz, O Kaiser, R Davies, A G Burger.   

Abstract

The induction of mixed function hepatic oxygenases by rifampicin is known to increase the metabolic clearance rate (MCR) of T4. By performing T3 and rT3 kinetics we have shown that rifampicin also increases the MCR of T3 and rT3. Using the fall of serum T4 during TSH suppression as an indirect marker of the production rate (PR) of T4, we have demonstrated that there was no major change in monodeiodination nor any shift to either 5'- or 5-monodeiodination. Rifampicin stimulates in mice the mixed function hepatic oxygenases. However, we were unable to increase hepatic deiodinase activity (deiodinase type I) in this species. It is therefore possible that the increased MCR of T4 in man is not mediated by an increased conversion rate either. As mixed function hepatic oxygenases are known to increase hepatic conjugation it is suggested that rifampicin increases the biliary excretion of iodothyronine conjugates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584854     DOI: 10.1007/bf03347182

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

1.  Letter: (to the editor). Erratum: revised calculations of common parameters of iodothyronine metabolism and distribution by noncompartmental analysis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

Review 2.  Multiple effects of 5,5'-diphenylhydantoin on the thyroid hormone system.

Authors:  P J Smith; M I Surks
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

3.  The monodeiodination of triiodothyronine and reverse triiodothyronine in man: a quantitative evaluation of the pathway by the use of turnover rate techniques.

Authors:  D Engler; U Merkelbach; G Steiger; A G Burger
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

4.  Effect of rifampicin on the mouse hepatic mixed-function oxidase system.

Authors:  J M Tredger; H M Smith; P R Powell-Jackson; M Davis; R Williams
Journal:  Biochem Pharmacol       Date:  1981-05-15       Impact factor: 5.858

5.  Iodothyronine 5'-deiodinase from rat kidney: substrate specificity and the 5'-deiodination of reverse triiodothyronine.

Authors:  J L Leonard; I N Rosenberg
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

6.  Determination of common parameters fo iodothyronine metabolism and distribution in man by noncompartmental analysis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

7.  The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.

Authors:  J Faber; I B Lumholtz; C Kirkegaard; S Poulsen; P H Jørgensen; K Siersbaek-Nielsen; T Friis
Journal:  J Clin Endocrinol Metab       Date:  1985-12       Impact factor: 5.958

8.  3'-isopropyl-3,5-diiodo-L-thyronine: a potent synthetic thyromimetic thyronine analog. Studies of its kinetics and biological potency in man and rats and its toxicology.

Authors:  C A Kaiser; N A Salomon-Montavon; U Merkelbach; A G Burger
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

9.  The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man.

Authors:  E E Ohnhaus; H Bürgi; A Burger; H Studer
Journal:  Eur J Clin Invest       Date:  1981-10       Impact factor: 4.686

  9 in total
  2 in total

1.  Type-2 iodothyronine 5'deiodinase in skeletal muscle of C57BL/6 mice. I. Identity, subcellular localization, and characterization.

Authors:  W Ramadan; A Marsili; S Huang; P R Larsen; J E Silva
Journal:  Endocrinology       Date:  2011-05-31       Impact factor: 4.736

2.  Rifampin-induced hypothyroidism.

Authors:  N Takasu; Y Kinjou; T Kouki; M Takara; Y Ohshiro; I Komiya
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.